Wockhardt退出美国非专利药物市场,因财政损失申请破产。 Wockhardt exits the US generic drug market, filing for bankruptcy due to financial losses.

一家印度制药公司Wockhardt因金融损失而退出美国非专利药品市场,为其美国子公司提出第7章破产申请。 Wockhardt, an Indian pharmaceutical company, is exiting the US generic drug market due to financial losses, filing for Chapter 7 bankruptcy for its US subsidiaries. 该公司计划将重点放在抗生素药物的发现和胰岛素产品上。 The company plans to focus on antibiotic drug discovery and insulin products. 尽管退出,Wockhardt将继续在印度、英国、爱尔兰和其他市场开展业务。 Despite the exit, Wockhardt will continue operations in India, the UK, Ireland, and other markets.